IGC Pharma (IGC) Current Leases (2023 - 2026)

IGC Pharma (IGC) reported Current Leases of $9000.0 for Q1 2026, down 90.43% year-over-year from $94000.0 in Q1 2025, and little changed quarter-over-quarter from $9000.0 in Q4 2025.

IGC Pharma (IGC) Current Leases (2023 - 2026) Analysis & Trends

IGC Pharma (IGC) has 4 years of Current Leases data on file, last reported at $9000.0 in Q1 2026.

  • Current Leases for Q1 2026 came in at $9000.0, down 90.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $9000.0 (down 90.43% YoY), and the FY2026 annual result was $9000.0, down 90.43% from the prior year.
  • Current Leases steadied at $9000.0 in Q1 2026 per IGC's latest filing, from $9000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $134000.0 in Q3 2024 and troughed at $9000.0 in Q3 2025.
  • A 4-year average of $86818.2 and a median of $124000.0 in 2023 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2024 and 2025: Current Leases changed 0.0% in 2024, then sank 93.28% in 2025.
  • A 4-year view of Current Leases shows it stood at $124000.0 in 2023, then changed by 0.0% to $124000.0 in 2024, then sank by 92.74% to $9000.0 in 2025, then changed by 0.0% to $9000.0 in 2026.
  • Business Quant data shows IGC's Current Leases at $9000.0 in Q1 2026, $9000.0 in Q4 2025, and $9000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 42,980.09
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 83,991.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 7.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 IGC Pharma 29.33 Mn 29.07 Mn - 9,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 9,000.00
Dec 31, 2025 9,000.00
Sep 30, 2025 9,000.00
Jun 30, 2025 62,000.00
Mar 31, 2025 94,000.00
Dec 31, 2024 124,000.00
Sep 30, 2024 134,000.00
Jun 30, 2024 133,000.00
Mar 31, 2024 124,000.00
Dec 31, 2023 124,000.00
Mar 31, 2023 133,000.00